Hina M. Porcelli

Conference Insider

Second-Line Triplet Combo Shows Promise in Patients With HER2+ Advanced GI/GEJ Cancer

06/02/2021

According to Sun Young Rha, MD, PhD, et al, second-line trastuzumab plus ramucirumab and paclitaxel showed promising activity and manageable safety in a study of patients with HER2+ GI/GEJ cancer.

According to Sun Young Rha, MD,...

06/02/2021

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Hina M. Porcelli

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products